Similar articles

• Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity.

  Dolphin A, Jenner P, Marsden CD. Dolphin A, et al. Pharmacol Biochem Behav. 1976 Oct;5(4):431-9. doi: 10.1016/0091-3057(76)90107-6. Pharmacol Biochem Behav. 1976. PMID: 1005491
• Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.

  Dolphin A, Jenner P, Marsden CD. Dolphin A, et al. Br J Pharmacol. 1975 Jun;54(2):246P-247P. Br J Pharmacol. 1975. PMID: 1148534 Free PMC article. No abstract available.
• Locomotor stimulation by L-dopa: relative importance of noradrenaline receptor activation.

  Andén NE, Strömbom U, Svensson TH. Andén NE, et al. Psychopharmacology (Berl). 1977 Nov 15;54(3):243-8. doi: 10.1007/BF00426571. Psychopharmacology (Berl). 1977. PMID: 413140
• Proceedings: Influence of H44/68 and FLA63 on central catecholamines and motor activity under light and darkness.

  Lemmer B, Berger T. Lemmer B, et al. Naunyn Schmiedebergs Arch Pharmacol. 1975;287 Suppl:R13. Naunyn Schmiedebergs Arch Pharmacol. 1975. PMID: 238144 No abstract available.
• Noradrenergic influences on dopaminergic function and the pharmacology of dihydroxyphenylserine (DOPS): implication for Parkinson's disease.

  Reches A. Reches A. Clin Neuropharmacol. 1985;8(3):249-59. doi: 10.1097/00002826-198509000-00005. Clin Neuropharmacol. 1985. PMID: 3930069 Review. No abstract available.